Yutaka Kawakami - Related publications

Affiliations: 
Keio University, Minato-ku, Tōkyō-to, Japan 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Parriott G, Deal K, Crean S, Richardson E, Nylen E, Barber A. T cells expressing a chimeric-PD1-Dap10-CD3zeta receptor reduce tumor burden in multiple murine syngeneic models of solid cancer. Immunology. PMID 32144940 DOI: 10.1111/imm.13187   
2020 Chai J, Han L, Zhang J, Han D, Zou L, Zhu Z, Zhao Y, Guo H. Conditional Reprogramming Inducing Clinical Cells Proliferation: New Research Tools in Tumor and Inflammatory-related Diseases. Current Pharmaceutical Design. PMID 32175833 DOI: 10.2174/1381612826666200316155252   
2020 Kim SD, Baik JS, Lee JH, Mun SW, Yi JM, Park MT. The malignancy of liver cancer cells is increased by IL-4/ERK/AKT signaling axis activity triggered by irradiated endothelial cells. Journal of Radiation Research. PMID 32100006 DOI: 10.1093/jrr/rraa002   
2020 Zhang Z, Liu S, Zhang B, Qiao L, Zhang Y, Zhang Y. T Cell Dysfunction and Exhaustion in Cancer. Frontiers in Cell and Developmental Biology. 8: 17. PMID 32117960 DOI: 10.3389/fcell.2020.00017   
2020 Ros-Martínez S, Navas-Carrillo D, Alonso-Romero JL, Orenes-Piñero E. Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies. Critical Reviews in Clinical Laboratory Sciences. 1-12. PMID 32175789 DOI: 10.1080/10408363.2020.1729692   
2020 Zhao J, Guo C, Xiong F, Yu J, Ge J, Wang H, Liao Q, Zhou Y, Gong Q, Xiang B, Zhou M, Li X, Li G, Xiong W, Fang J, et al. Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal cancer. Cancer Letters. PMID 32061950 DOI: 10.1016/j.canlet.2020.02.010   
2020 Xu J, Luo Y, Yuan C, Han L, Wu Q, Xu L, Gao Y, Sun Y, Ma S, Tang G, Li S, Sun W, Gong Y, Xie C. Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration. International Journal of Biological Sciences. 16: 1563-1574. PMID 32226302 DOI: 10.7150/ijbs.41653   
2020 Manjunath Y, Porciani D, Mitchem JB, Suvilesh KN, Avella DM, Kimchi ET, Staveley-O'Carroll KF, Burke DH, Li G, Kaifi JT. Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer. International Journal of Molecular Sciences. 21. PMID 32182935 DOI: 10.3390/ijms21051872   
2020 Sun T, Yang W, Toprani SM, Guo W, He L, DeLeo AB, Ferrone S, Zhang G, Wang E, Lin Z, Hu P, Wang X. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram. Cell Communication and Signaling : Ccs. 18: 36. PMID 32138738 DOI: 10.1186/s12964-019-0507-3   
2020 Routh ED, Pullikuth AK, Jin G, Chifman J, Chou JW, D'Agostino RB, Seino KI, Wada H, Print CG, Zhang W, Lu Y, Miller LD. Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types. Frontiers in Immunology. 11: 57. PMID 32117236 DOI: 10.3389/fimmu.2020.00057   
2020 Minute L, Teijeira A, Sanchez-Paulete AR, Ochoa MC, Alvarez M, Otano I, Etxeberrria I, Bolaños E, Azpilikueta A, Garasa S, Casares N, Luis Perez Gracia J, Rodriguez-Ruiz ME, Berraondo P, Melero I. Cellular cytotoxicity is a form of immunogenic cell death. Journal For Immunotherapy of Cancer. 8. PMID 32217765 DOI: 10.1136/jitc-2019-000325   
2020 Shi Y, Men X, Li X, Yang Z, Wen H. Research progress and clinical prospect of immunocytotherapy for the treatment of hepatocellular carcinoma. International Immunopharmacology. 82: 106351. PMID 32143005 DOI: 10.1016/j.intimp.2020.106351   
2020 Wu J, Wang Y, Jiang Z. TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer. Journal of Gastrointestinal Cancer. PMID 32077004 DOI: 10.1007/s12029-020-00371-6   
2020 Du X, He K, Huang Y, Xu Z, Kong M, Zhang J, Cao J, Teng L. Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target. International Journal of Oncology. PMID 32124956 DOI: 10.3892/ijo.2020.4965   
2020 Chen JA, Ma W, Yuan J, Li T. Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors. Cancer Treatment and Research. 180: 251-279. PMID 32215873 DOI: 10.1007/978-3-030-38862-1_9   
2020 Khan S, Mittal S, McGee K, Alfaro-Munoz KD, Majd N, Balasubramaniyan V, de Groot JF. Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance. International Journal of Molecular Sciences. 21. PMID 32182988 DOI: 10.3390/ijms21061954   
2020 Praktiknjo SD, Obermayer B, Zhu Q, Fang L, Liu H, Quinn H, Stoeckius M, Kocks C, Birchmeier W, Rajewsky N. Tracing tumorigenesis in a solid tumor model at single-cell resolution. Nature Communications. 11: 991. PMID 32080185 DOI: 10.1038/s41467-020-14777-0   
2020 Li B, Li T, Liu JS, Liu XS. Computational Deconvolution of Tumor-Infiltrating Immune Components with Bulk Tumor Gene Expression Data. Methods in Molecular Biology (Clifton, N.J.). 2120: 249-262. PMID 32124325 DOI: 10.1007/978-1-0716-0327-7_18   
2020 Shen Y, Schmidt BUS, Kubitschke H, Morawetz EW, Wolf B, Käs JA, Losert W. Detecting heterogeneity in and between breast cancer cell lines. Cancer Convergence. 4: 1. PMID 32090168 DOI: 10.1186/s41236-020-0010-1   
2020 Bianchi JJ, Zhao X, Mays JC, Davoli T. Not all cancers are created equal: Tissue specificity in cancer genes and pathways. Current Opinion in Cell Biology. 63: 135-143. PMID 32092639 DOI: 10.1016/j.ceb.2020.01.005   
2020 Moufarrij S, Srivastava A, Gomez S, Hadley M, Palmer E, Austin PT, Chisholm S, Roche K, Yu A, Li J, Zhu W, Lopez-Acevedo M, Villagra A, Chiappinelli KB. Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer. Scientific Reports. 10: 3470. PMID 32103105 DOI: 10.1038/s41598-020-60409-4   
2020 Liu X, Hoft DF, Peng G. Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy. The Journal of Clinical Investigation. 130: 1073-1083. PMID 32118585 DOI: 10.1172/JCI133679   
2020 Gerber HP, Sibener LV, Lee LJ, Gee MH. Identification of Antigenic Targets. Trends in Cancer. 6: 299-318. PMID 32209445 DOI: 10.1016/j.trecan.2020.01.002   
2020 Liu Z, Fu YX. Chemotherapy Induces Cancer-Fighting B Cells. Cell. PMID 32142652 DOI: 10.1016/j.cell.2020.02.046   
2020 Lopès A, Billard E, Casse AH, Villéger R, Veziant J, Roche G, Carrier G, Sauvanet P, Briat A, Pagès F, Naimi S, Pezet D, Barnich N, Dumas B, Bonnet M. Colibactin-positive E. coli induce a pro-carcinogenic immune environment leading to immunotherapy resistance in colorectal cancer. International Journal of Cancer. PMID 32037530 DOI: 10.1002/ijc.32920   
2020 Li S, Sun Y, Huang J, Wang B, Gong Y, Fang Y, Liu Y, Wang S, Guo Y, Wang H, Xu Z, Guo Y. Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: Status and prospect. Journal of Ethnopharmacology. 112797. PMID 32243990 DOI: 10.1016/j.jep.2020.112797   
2020 Cai MC, Zhao X, Cao M, Ma P, Chen M, Wu J, Jia C, He C, Fu Y, Tan L, Xue X, Yu Z, Zhuang G. T cell exhaustion interrelates with immune cytolytic activity to shape inflamed tumor microenvironment. The Journal of Pathology. PMID 32222046 DOI: 10.1002/path.5435   
2020 Zhang W, Hu X, Liang J, Zhu Y, Zeng B, Feng L, Zhao C, Liu S, Liu B, Zhang K. oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity. Molecular Therapy Oncolytics. 16: 158-171. PMID 32055679 DOI: 10.1016/j.omto.2019.12.012   
2020 Johnson AM, Bullock BL, Neuwelt AJ, Poczobutt JM, Kaspar RE, Li HY, Kwak JW, Hopp K, Weiser-Evans MCM, Heasley LE, Schenk EL, Clambey ET, Nemenoff RA. Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma. Journal of Immunology (Baltimore, Md. : 1950). PMID 32179637 DOI: 10.4049/jimmunol.1900778   
2020 Kokolus KM, Obermajer N, Kalinski P. Quantitative evaluation of tumor-specific T cells in tumors and lymphoid tissues. Methods in Enzymology. 635: 149-166. PMID 32122543 DOI: 10.1016/bs.mie.2019.05.041   
2020 Wehr J, Sikorski EL, Bloch E, Feigman MS, Ferraro NJ, Baybutt TR, Snook AE, Pires MM, Thévenin D. pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated Cytotoxicity. Journal of Medicinal Chemistry. PMID 32196345 DOI: 10.1021/acs.jmedchem.0c00016   
2020 Ruan H, Leibowitz BJ, Zhang L, Yu J. Immunogenic cell death in colon cancer prevention and therapy. Molecular Carcinogenesis. PMID 32215970 DOI: 10.1002/mc.23183   
2020 Taghikhani A, Farzaneh F, Sharifzad F, Mardpour S, Ebrahimi M, Hassan ZM. Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy. Frontiers in Immunology. 11: 221. PMID 32210954 DOI: 10.3389/fimmu.2020.00221   
2020 Sadasivam S, Subramanian R. A perspective on challenges and opportunities in characterizing oral cancer stem cells. Frontiers in Bioscience (Landmark Edition). 25: 1011-1021. PMID 32114422   
2020 Wijesekera DPH, Yuba E, De Silva NH, Watanabe SI, Tsukamoto M, Ichida C, Izawa T, Itoh K, Kanegi R, Hatoya S, Yamate J, Inaba T, Sugiura K. Manipulation of the tumor microenvironment by cytokine gene transfection enhances dendritic cell-based immunotherapy. Faseb Bioadvances. 2: 5-17. PMID 32123853 DOI: 10.1096/fba.2019-00052   
2020 Luo X, Han G, Lu R, Guan S, Wang Y, Ju L, Chen L, Shao J, Bian Z. Transmembrane protein 106C promotes the development of hepatocellular carcinoma. Journal of Cellular Biochemistry. PMID 32037603 DOI: 10.1002/jcb.29678   
2020 Goldsberry WN, Meza-Perez S, Londoño AI, Katre AA, Mott BT, Roane BM, Goel N, Wall JA, Cooper SJ, Norian LA, Randall TD, Birrer MJ, Arend RC. Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment. Cancers. 12. PMID 32213921 DOI: 10.3390/cancers12030766   
2020 Yamaguchi R, Perkins G. An Emerging Model for Cancer Development from a Tumor Microenvironment Perspective in Mice and Humans. Advances in Experimental Medicine and Biology. 1225: 19-29. PMID 32030645 DOI: 10.1007/978-3-030-35727-6_2   
2020 Silva AL, Faria M, Matos P. Inflammatory Microenvironment Modulation of Alternative Splicing in Cancer: A Way to Adapt. Advances in Experimental Medicine and Biology. 1219: 243-258. PMID 32130703 DOI: 10.1007/978-3-030-34025-4_13   
2020 Chiu D, Tavaré R, Haber L, Aina OH, Vazzana K, Ram P, Danton M, Finney J, Jalal S, Krueger P, Giurleo JT, Ma D, Smith E, Thurston G, Kirshner JR, et al. A PSMA-targeting CD3 bispecific antibody induces antitumor responses that are enhanced by 4-1BB costimulation. Cancer Immunology Research. PMID 32184296 DOI: 10.1158/2326-6066.CIR-19-0518   
2020 Achyut BR, Zhang H, Angara K, Mivechi NF, Arbab AS, Ko L. Oncoprotein GT198 Vaccination Delays Tumor Growth in MMTV-PyMT Mice. Cancer Letters. PMID 32061755 DOI: 10.1016/j.canlet.2020.02.005   
2020 Luo Y, Yang J, Yu J, Liu X, Yu C, Hu J, Shi H, Ma X. Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment. Frontiers in Oncology. 10: 48. PMID 32083005 DOI: 10.3389/fonc.2020.00048   
2020 Wang S, Wang X, Zhou X, Lyerly HK, Morse MA, Ren J. DC-CIK as a widely applicable cancer immunotherapy. Expert Opinion On Biological Therapy. PMID 32033522 DOI: 10.1080/14712598.2020.1728250   
2020 Lee YS, Cho YB. CCL7 Signaling in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1231: 33-43. PMID 32060844 DOI: 10.1007/978-3-030-36667-4_4   
2020 Millar DG, Ramjiawan RR, Kawaguchi K, Gupta N, Chen J, Zhang S, Nojiri T, Ho WW, Aoki S, Jung K, Chen I, Shi F, Heather JM, Shigeta K, Morton LT, et al. Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy. Nature Biotechnology. PMID 32042168 DOI: 10.1038/s41587-019-0404-8   
2020 Kim BJ, Hannanta-Anan P, Ryd A, Swartz MA, Wu M. Lymphoidal chemokine CCL19 promoted the heterogeneity of the breast tumor cell motility within a 3D microenvironment revealed by a Lévy distribution analysis. Integrative Biology : Quantitative Biosciences From Nano to Macro. PMID 32055833 DOI: 10.1093/intbio/zyaa001   
2020 Yu X, Wang Z, Zeng T. Essential gene expression pattern of head and neck squamous cell carcinoma revealed by tumor-specific expression rule based on single-cell RNA sequencing. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165791. PMID 32234410 DOI: 10.1016/j.bbadis.2020.165791   
2020 Yang H, Xuefeng Y, Jianhua X. Systematic Review of the Roles of Interleukins in Hepatocellular Carcinoma. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 32142718 DOI: 10.1016/j.cca.2020.03.001   
2020 Banik G, Betts CB, Liudahl SM, Sivagnanam S, Kawashima R, Cotechini T, Larson W, Goecks J, Pai SI, Clayburgh DR, Tsujikawa T, Coussens LM. High-dimensional multiplexed immunohistochemical characterization of immune contexture in human cancers. Methods in Enzymology. 635: 1-20. PMID 32122539 DOI: 10.1016/bs.mie.2019.05.039   
2020 de Almeida PE, Mak J, Hernandez G, Jesudason R, Herault A, Javinal V, Borneo J, Kim JM, Walsh KB. Anti-VEGF Treatment Enhances CD8+ T-Cell Antitumor Activity by Amplifying Hypoxia. Cancer Immunology Research. PMID 32238381 DOI: 10.1158/2326-6066.CIR-19-0360